184 related articles for article (PubMed ID: 17223160)
41. MT1-selective melatonin receptor ligands: synthesis, pharmacological evaluation, and molecular dynamics investigation of N-{[(3-O-substituted)anilino]alkyl}amides.
Rivara S; Pala D; Lodola A; Mor M; Lucini V; Dugnani S; Scaglione F; Bedini A; Lucarini S; Tarzia G; Spadoni G
ChemMedChem; 2012 Nov; 7(11):1954-64. PubMed ID: 22927210
[TBL] [Abstract][Full Text] [Related]
42. 2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.
Zlotos DP; Attia MI; Julius J; Sethi S; Witt-Enderby PA
J Med Chem; 2009 Feb; 52(3):826-33. PubMed ID: 19193160
[TBL] [Abstract][Full Text] [Related]
43. N-Acetyl-5-arylalkoxytryptamine analogs: probing the melatonin receptors for MT(1) -selectivity.
Markl C; Clafshenkel WP; Attia MI; Sethi S; Witt-Enderby PA; Zlotos DP
Arch Pharm (Weinheim); 2011 Oct; 344(10):666-74. PubMed ID: 21887801
[TBL] [Abstract][Full Text] [Related]
44. Recent advances in melatonin receptor ligands.
Zlotos DP
Arch Pharm (Weinheim); 2005 Jun; 338(5-6):229-47. PubMed ID: 15952241
[TBL] [Abstract][Full Text] [Related]
45. Study of the effects of the casein derived bitter tastant on the melanophores in milieu with the melatonin receptors.
Mubashshir M; Ahmed F; Ovais M
J Recept Signal Transduct Res; 2011 Oct; 31(5):381-6. PubMed ID: 21929292
[TBL] [Abstract][Full Text] [Related]
46. Synthesis of N1-phenethyl substituted indole derivatives as new melatoninergic agonists and antagonists.
Tsotinis A; Vlachou M; Eleutheriades A; Prinea E; Ebreo D; The MT; Sugden D
Chem Pharm Bull (Tokyo); 2002 Jan; 50(1):31-9. PubMed ID: 11824582
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and study of pigment aggregation response of some melatonin derivatives.
Doss SH; Mohareb RM; Elmegeed GA; Luoca NA
Pharmazie; 2003 Sep; 58(9):607-13. PubMed ID: 14531452
[TBL] [Abstract][Full Text] [Related]
48. Molecular cloning and pharmacological characterization of monkey MT1 and MT2 melatonin receptors showing high affinity for the agonist ramelteon.
Nishiyama K; Shintani Y; Hirai K; Yoshikubo S
J Pharmacol Exp Ther; 2009 Sep; 330(3):855-63. PubMed ID: 19556449
[TBL] [Abstract][Full Text] [Related]
49. Preparation of 4-azaindole and 7-azaindole dimers with a bisalkoxyalkyl spacer in order to preferentially target melatonin MT1 receptors over melatonin MT2 receptors.
Larraya C; Guillard J; Renard P; Audinot V; Boutin JA; Delagrange P; Bennejean C; Viaud-Massuard MC
Eur J Med Chem; 2004 Jun; 39(6):515-26. PubMed ID: 15183910
[TBL] [Abstract][Full Text] [Related]
50. Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands: requirements for subtype selectivity and intrinsic activity modulation.
Rivara S; Mor M; Silva C; Zuliani V; Vacondio F; Spadoni G; Bedini A; Tarzia G; Lucini V; Pannacci M; Fraschini F; Plazzi PV
J Med Chem; 2003 Apr; 46(8):1429-39. PubMed ID: 12672242
[TBL] [Abstract][Full Text] [Related]
51. Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits.
Alarma-Estrany P; Guzman-Aranguez A; Huete F; Peral A; Plourde R; Pelaez T; Yerxa B; Pintor J
J Pharmacol Exp Ther; 2011 Jun; 337(3):703-9. PubMed ID: 21368006
[TBL] [Abstract][Full Text] [Related]
52. N-[2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl]acetamide: an orally bioavailable melatonin receptor agonist.
Sun LQ; Takaki K; Chen J; Iben L; Knipe JO; Pajor L; Mahle CD; Ryan E; Xu C
Bioorg Med Chem Lett; 2004 Oct; 14(20):5157-60. PubMed ID: 15380218
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and functional characterization of substituted isoquinolinones as MT2-selective melatoninergic ligands.
Hu Y; Chan KH; He X; Ho MK; Wong YH
PLoS One; 2014; 9(12):e113638. PubMed ID: 25479338
[TBL] [Abstract][Full Text] [Related]
54. Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines.
Spadoni G; Bedini A; Lucarini S; Mari M; Caignard DH; Boutin JA; Delagrange P; Lucini V; Scaglione F; Lodola A; Zanardi F; Pala D; Mor M; Rivara S
J Med Chem; 2015 Sep; 58(18):7512-25. PubMed ID: 26334942
[TBL] [Abstract][Full Text] [Related]
55. Strategies leading to MT2 selective melatonin receptor antagonists.
Spadoni G; Bedini A; Piersanti G; Mor M; Rivara S; Tarzia G
Adv Exp Med Biol; 2003; 527():577-85. PubMed ID: 15206776
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of new tricyclic melatoninergic ligands.
Tsotinis A; Panoussopoulou M; Sivananthan S; Sugden D
Farmaco; 2001 Sep; 56(9):725-9. PubMed ID: 11680819
[TBL] [Abstract][Full Text] [Related]
57. 1-(2-Alkanamidoethyl)-6-methoxyindole derivatives: a new class of potent indole melatonin analogues.
Tarzia G; Diamantini G; Di Giacomo B; Spadoni G; Esposti D; Nonno R; Lucini V; Pannacci M; Fraschini F; Stankov BM
J Med Chem; 1997 Jun; 40(13):2003-10. PubMed ID: 9207941
[TBL] [Abstract][Full Text] [Related]
58. Reassessing the melatonin pharmacophore--enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue.
Rivara S; Diamantini G; Di Giacomo B; Lamba D; Gatti G; Lucini V; Pannacci M; Mor M; Spadoni G; Tarzia G
Bioorg Med Chem; 2006 May; 14(10):3383-91. PubMed ID: 16431121
[TBL] [Abstract][Full Text] [Related]
59. Aggregation of pigment granules in single cultured Xenopus laevis melanophores by melatonin analogues.
Sugden D
Br J Pharmacol; 1991 Dec; 104(4):922-7. PubMed ID: 1667293
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and cytotoxic activity of N-[(alkylamino)alkyl]carboxamide derivatives of 7-oxo-7H-benz[de]anthracene, 7-oxo-7H-naphtho[1,2,3-de]quinoline, and 7-oxo-7H-benzo[e]perimidine.
Bu X; Chen J; Deady LW; Smith CL; Baguley BC; Greenhalgh D; Yang S; Denny WA
Bioorg Med Chem; 2005 Jun; 13(11):3657-65. PubMed ID: 15862994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
